Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TEMPLE - Thiopurine Enhanced Mutations for PD-1/Ligand-1 Efficacy

NCT05276284 is registered in ClinicalTrials.gov with Kristoffer Rohrberg as lead sponsor.

NCT NCT05276284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05276284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TEMPLE - Thiopurine Enhanced Mutations for PD-1/Ligand-1 Efficacy
Lead sponsor
Kristoffer Rohrberg
Phase
Phase 1/2
Overall status
Completed
Start date
September 1, 2022
Completion date
September 1, 2025
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer, solid tumor, adult